statement: The kinetics of asymmetric DNA methylation acquisition of embryo-23 placenta differentially methylated regions is not a stepwise process occurring in embryonic and 24 extraembryonic lineages, but a prompt progression in the early post-implanted conceptus. 25 26 ABSTRACT 27 28
INTRODUCTION 44
Throughout the eutherian mammalian gestation, the placenta plays an essential role in 45 mediating maternal-embryonic exchanges of gas, nutrients and waste, and also provides the 46 developing embryo with a protective layer against adverse environmental exposures and the 47 maternal immune system (Rossant and Cross, 2001) . These unique placental functions are 48 orchestrated by several distinct trophoblast cell subtypes organized in separate layers (Cross, 49 2000) . The initial steps of lineage specialization of both placental and embryonic cells occur 50 promptly following fertilization during the first few embryonic cleavages as DNA methylation 51 marks are being reprogrammed (Morgan et al., 2005) . 52 DNA methylation is an epigenetic mechanism that is critical in the determination of 53 lineage-specific differentiation and development, and is mainly recognized for its involvement in 54 processes such as transcriptional repression, genomic imprinting and X-inactivation (Bestor, 55 2000) . DNA methylation marks are mediated by the action of DNA methyltransferases 56 (DNMTs). Establishment of new or de novo DNA methylation patterns required for cell lineage 57 determination during development is mediated by DNMT3A and DNMT3B, with cofactor 58 DNMT3L, (Okano et al., 1999 , Li, 2002 , whereas DNMT1 maintains heritable DNA 59 methylation patterns during cellular divisions (Leonhardt et al., 1992 , Lei et al., 1996 . These 60 enzymes are critical, as deletion of Dnmt3b or Dnmt1 is embryonic lethal, while Dnmt3a-61 deficient offspring die shortly after birth (Li et al., 1992 , Okano et al., 1999 . During 62 gametogenesis, the acquisition of genome-wide and allele-specific methylation patterns (i.e. 63 genomic imprinting) in both oocytes and sperm is essentially due to the activity of DNMT3A 64 (Kaneda et al., 2004 , Kato et al., 2007 . Following fertilization, a reprogramming wave removes 65 most methylation signatures across the genome, except for imprinted regions, some types of 66 repeat sequences, as well as imprinted-like sequences, to trigger the developmental program 67 (Hirasawa et al., 2008 , Howell et al., 2001 . Then, during the peri-68 implantation process, DNA methylation profiles are re-acquired in a sex-, cell-and tissue-69 specific manner across most parts of the genome by the combined action of DNMT3A and 70 DNMT3B. In the early stages of the de novo methylation wave (E4.5-E7.5), the expression of 71
Dnmt3b is more robust than Dnmt3a in the epiblast and embryonic-derived cells (Watanabe et Dnmt3a being considerably reduced in the extraembryonic ectoderm (ExE) and trophoblast 74 lineages (Smith et al., 2017 , Senner et al., 2012 . This discrepancy in Dnmt3a and Dnmt3b 75 expression levels coincides with the initiation of divergent DNA methylation acquisition 76 between the trophoblast and the inner cell mass of the blastocyst (Monk, 1987, Nakanishi et Although the functional role of reduced methylation levels observed across the placental 85 genome is still not fully understood, studies suggest that it may activate transposable elements 86 that are typically silenced in other tissues (Chuong, 2013). DNA methylation plays an important 87 role in suppressing retrotransposons in mammalian cells, for which the activity has been 88 associated with genomic instability and disease development (Church et al., 2009, Slotkin and 89 Martienssen, 2007) . Following the de novo methylation wave, in embryonic-derived cells from 90 the inner cell mass, transposable elements acquire higher levels of DNA methylation causing 91 transcriptional silencing, whereas in the trophectoderm-derived cells that will form the placenta, 92 these transposable elements are maintained in a relaxed methylation state and preferentially 93 expressed (Price et al., 2012 , Okahara et al., 2004 , Warren et al., 2015 . The low-methylation 94 levels on these elements contributed to the evolution and diversification of the placenta function 95 through the regulation of gene expression by providing placenta-specific enhancers, cryptic 96 promoters and other cis-regulatory elements (Haig, 2012, Mi et 2019) of embryos and their corresponding placentas at mid-gestation (E10.5), the developmental 150 stage at which the mouse placenta is considered mature (Cross et al., 1994) . Using this approach, 151 we quantified the DNA methylation profiles of ~1.8 million CpG sites in each sample (embryo 152 n=4, placenta n=4). We found that the accumulation of CpG methylation was very distinct 153 between the placenta and the embryo. In the placenta, we detected a greater proportion of CpGs 154 in the 0-50% methylation range and a lower proportion of CpGs in the 80-100% methylation 155 range ( Figure 1A ). Although we observed that a large proportion of CpGs within the examined 156 regions had no methylation marks in both the embryo and the placenta, interestingly, most CpGs 157 with partial methylation (20-50%) in placenta showed high methylation levels (>80%) in 158 embryos ( Figure 1B ). The divergence in global DNA methylation profiles conferred a high 159 degree of clustering between both tissue types ( Figure S1 ). These results are consistent with 160 previous studies indicating lower levels of overall DNA methylation in extraembryonic tissues 161 To further investigate the dynamics of DNA methylation between placental and 164 embryonic genomes and enable direct comparison of precise regions, we segmented the genome 165 of autosomal chromosomes into 100bp non-overlapping genomic windows (tiles; see methods 166 section). After removal of sex chromosomes, we identified 245 048 unique sequenced tiles 167 (referred to as All-tiles) containing 896 820 common CpGs between all placenta and embryo 168 samples and with a minimum of 15x sequencing depth. We observed a strong reduction in the 169 fraction of highly methylated tiles (80-100%) in the placenta compared to the embryo (Figure  170 1C), which correlated with a sharp increase in the number of placenta tiles in the 0-20%, 20-40% 171 and 40-60% methylation range. Globally, we found that the average DNA methylation level 172 across all placental tiles was significantly lower compared to all embryo tiles (27% vs 45%, 173 p<0.0001) ( Figure 1C ). This overall epigenetic disparity in embryo and placenta DNA 174 methylation levels was especially noticeable when we mapped the methylation mean of All-tiles 175 with respect to regions surrounding the transcription start sites (TSS) ( Figure 1D ). When we 176 focused on a specific chromosome section (e.g., chr 7, 35Mb) ( Figure 1E ), we observed that 177 genomic segments with high DNA methylation levels in embryos were predominantly 178 hypomethylated in placenta. We also observed that gene or CpG island (CGI) poor regions had 179 consistently high methylation levels in embryos and lower methylation levels in the placenta. 180
Together, these results indicate that the mid-gestation placenta has very distinctive global DNA 181 methylation profiles compared to the embryo, and that this lower level of global DNA 182 methylation (i.e., DNA hypomethylation) across the placental genome is due to a significant 183 lower number of highly methylated (≥80%) genomic regions. We can also conclude that despite 184 the cellular heterogeneity in E10.5 placental and embryonic tissues, the vast majority of the 185 conceptus possesses specific genomic regions with either low (0-20%) or high (80-100%) levels 186 of methylation. However, the placenta genome presents an increased number of regions having a 187 broader distribution of DNA methylation (20-80%), revealing a greater diversity in methylation 188 levels across placental cell types compared to embryonic cell types. 189
190

Embryonic and Placental DNA Methylation Divergences Across Genomic Features 191
To explain the developmentally divergent methylated states between the mouse embryo 192 and the placenta, we next sought to precisely determine the genomic features revealing DNA 193 methylation differences. We defined differentially methylated regions ( Consistent with our findings (Figure 1 ), the majority (96.8%; n=106 712) of DMRs had lower 201 DNA methylation in the placenta (referred to as Hypo-DMRs) and only a small proportion 202 (3.2%; n=3 528) showed increased methylation levels (referred to as Hyper-DMRs) compared to 203 the embryo ( Figure S2 ). For Hypo-DMRs, tiles mainly overlapped (96%; n=102 982) with 204 intergenic, intron, exon and promoter-TSS regions ( Figure S2 ). For each of the genomic feature 205 categories of Hypo-DMRs, the average DNA methylation levels in the placenta were essentially 206 half of those present in the embryo ( Figure 2B ). As for DMRs with higher methylation levels in 207 the placenta (Hyper-DMRs), we noticed that the vast majority of these tiles (83%; n=2 929) had 208 very low methylation levels in the embryo (<20%) (Figure 2A (Mizuuchi et al., 2016) . As for genes predominantly expressed in the 217 embryo, Mir219a-2/Mir219b, a brain-specific non-coding microRNA, showed higher 218 methylation in the placenta ( Figure 2D ). It was recently shown that Mir219 was abnormally 219 expressed during pregnancy in amnion retrieved specifically from obese women (Nardelli et al., 220 2014) and, interestingly, obesity has been suggested to cause epigenetic changes (Lillycrop and 221 Burdge, 2011). Another example of placenta Hyper-DMRs is Sox6 (SRY-Box 6), which is 222 implicated in the terminal differentiation of muscle ( Figure 2D ) (Kamachi and Kondoh, 2013) . 223
These observations point to an association between tissue-specific DNA methylation levels of 224 DMRs and biological functions. Gene ontology enrichment analyses further support that Hypo-225 DMRs were strongly associated to germline functions and reproduction (e.g., male and female 226 gamete generation, reproduction, piRNA metabolic process, meiotic cell cycle, germ cell 227 development) ( Figure 2C ). As for Hyper-DMRs, top biological processes were mostly associated 228 with developmental and differentiation processes (e.g., regionalization, embryo development, 229 pattern specification process, skeletal system, head development) ( Figure 2C ). Fittingly, the 230 biological functions were completely divergent between Hypo-and Hyper-DMRs. Altogether, 231 these results denote that Hypo-and Hyper-DMRs are present across genomic features between 232 mid-gestation embryo and placenta, and that these DNA methylation divergences are implicated 233 in promoting/repressing specific processes during embryonic and placental development. 234 235
Presence of Distinctive DMR Categories between Mid-Gestation Embryo and Placenta 236
Amongst DMRs, our analyses also suggest the presence of particular DMR categories 237 based on their level of DNA methylation in the embryo and placenta (Figure 2A ). By defining 238 subsets of DMRs and establishing their dynamic properties between tissues, we might better 239 understand the genome-wide asymmetry in DNA methylation levels observed between the 240 embryo and the placenta. To do so, we first clustered DMR-associated tiles in 6 different 241 categories based on their range of low, mid and high methylation level (Low; <20%, Mid; ≥ 20 to 242 <80%, High; ≥ 80%) in the embryo and the placenta, and followed the DMR category transitions 243 between both tissues. We observed that DMRs with High-levels of methylation in the embryo 244 overlapped with a large proportion of DMRs that showed Mid-levels of methylation in the 245 placenta ( Figure 3A 
Specific Genomic Features Associated with DMR Categories 259
We next aimed to determine if the genomic distribution of embryo-placenta DMR 260 categories was associated with distinct genomic features. First, by classifying by genomic 261 annotations, we observed that DMRs with reduced methylation levels in the placenta (High-Mid, 262
High-Low, Mid-Low) were prevailingly found in intergenic regions (>50% of tiles) ( Figure 3C ), 263
whereas DMR categories with equivalent (Mid-Mid) or superior methylation level (Mid-High, 264
Low-Mid) in the placenta were more frequent in genic associated regions (>50% of tiles). 265
However, divergence between DMR categories was observed when we performed ontology 266 analyses on promoter regions ( Figure S3 ), as each DMR subtype clearly showed distinct 267 biological functions. For example, High-Mid DMRs top functions were related to genes (e.g., 268
Aszl, Tnp1, Piwil2) associated with male gamete generation, piRNA metabolic process and male 269 meiotic nuclear division, whereas those of the Low-Mid category were mostly associated with 270 developmental aspects (e.g., skeletal system development, regionalization, nervous system 271 development). Since we know that in placenta, activation of retrotransposon-derived genes is shores and shelves, revealing that the acquisition of de novo methylation for these genomic 290 fragments in the extraembryonic lineage preferentially targets sequences inside or surrounding 291
CGIs. 292
Altogether, these results indicate that the asymmetry within DMR categories, based on 293 their methylation levels in the embryo and the placenta, can be associated to specific biological 294 functions and genomic-derived features (e.g., CpG, retrotransposon contents). This is particularly 295 apparent for DMRs with High-levels in the embryo (High-Mid, High-Low) and those with higher 296 methylation levels in the placenta (Low-Mid). analyzed using our custom script to generate 100bp tiles, and the DNA methylation levels for 305 each tile were calculated. In E3.5 blastocysts, when the mouse genome is mostly depleted from 306 DNA methylation marks, we observed low global DNA methylation levels (average <20%) for 307 all DMR subtypes, with similar median levels between the committed cells of the inner cell mass 308 (ICM) and trophectoderm lineages (Figure 4 ). DNA methylation levels tended to be higher in the 309 trophectoderm for regions falling in the Mid-High DMRs, although measurements are based on 310 very few DMRs for this specific category (n=21, Figure 3B , Mid-High). Since global DNA 311 methylation is re-acquired in the next few subsequent developmental stages, we then asked 312 whether the contrast in DNA methylation levels associated with the various DMR categories at 313 mid-gestation would already be present between E6.5 epiblast and extraembryonic ectoderm 314 (ExE) cell lineages, layers that are mostly composed of homogeneous and undifferentiated cell 315 populations. For all DMR categories, DNA methylation levels in the E6.5 epiblast and ExE 316 already showed similar pattern trends to those observed in the E10.5 embryo and placenta 317 ( Figure 4 , Table S2 ). Interestingly, for all DMR categories we observed slightly higher DNA 318 methylation levels in E6.5 ExE compared to E10.5 placenta (Figure 4 , Table S2 ). However, 319
when measured in the subsequent developmental stages (E10.5, E11.5, E15 and E18), levels 320 associated with each category stabilized and remained in the same methylation range. This is true 321 for all categories, except for the Mid-High DMRs where methylation levels are reduced by ~20% 322 at E18. As for the E6.5 epiblast DNA methylation profiles, they closely matched those observed 323 in the E10.5 embryo, except again for the Mid-High DMRs. For each of the DMR subtypes, the 324 DNA methylation levels were largely stable and persisted across other time points (E6.5, E10.5, 325 E11.5) in embryonic cells. Although no public DNA methylation data were available for whole 326 embryos at later stages, when we overlapped tiles associated with E10.5 DMR categories with 327 data from differentiated tissues of adult mice, the global DNA methylation profiles closely 328 matched those for the majority of DMR categories (High-Mid, High-Low, Mid-Mid and Mid-329 Low) (Figure 4, Figure S4 ). We conclude that the various DMR categories observed at E10.5 are 330 established during the embryonic and extraembryonic lineage-specification processes occurring 331 during the peri-implantation wave of de novo methylation, and that these DNA methylation 332 landscapes are widely retained throughout embryo and placenta development. Furthermore, for 333 most DMR categories, the DNA methylation levels observed in developing embryos are long-334 lasting and conserved throughout somatic cell differentiation. 335 336
Dnmt3a-or Dnmt3b-Deficiency Alters Proper Establishment of DMR-Associated Patterns 337
Since the combined activity of DNMT3A and DNMT3B is essential for proper 338 establishment of DNA methylation profiles and normal development, we next sought to define 339 the contribution of each enzyme in the de novo establishment of DNA methylation in subtypes of 340 DMRs in embryonic and extraembryonic cell lineages. To do so, we used DNA methylation data 341 from publicly available datasets (whole genome bisulfite sequencing and RRBS) at E6.5 342 (epiblast and ExE) and E8.5 (embryo) with various inactive forms of Dnmts. First, when we 343 overlapped our All-tiles subset, we observed a substantial reduction (p 0.0001) in average DNA 344 methylation in absence of DNMT3A (37.81%) or DNMT3B (31.48%) in the E6.5 epiblast 345 compared to wild-type (44.81%), whereas in the E6.5 ExE such a comparable loss was only 346 associated with a Dnmt3b-deficiency (wt: 34.38% vs Dnmt3b -/-: 19.33%, p 0.0001) ( Figure S5 ). 347
Similarly, in the E8.5 embryo, a significant reduction in average DNA methylation level was 348 measured with lack of Dnmt3a or Dnmt3b expression compared to wild-type (wt: 47.5%; 349
Dnmt3a -/-: 43.6%; Dnmt3b -/-: 34%, p 0.0001) ( Figure S5 ). For most DMR subtypes, absence of 350 DNMT3A caused modest or no reduction on overall DNA methylation levels in E6.5 epiblast 351 and ExE ( Figure 5A and S6, Table S3 ). Intriguingly, Dnmt3a-deficiency caused a slight gain of 352 methylation (wt: 76.9% vs Dnmt3a -/-: 81.5%, p 0.0001) level in the E6.5 epiblast for High-Mid 353
DMRs, suggesting a potential overcompensation effect by DNMT3B in the epiblast on this 354 specific DMR subtype. In comparison, Dnmt3b-depletion led to a substantial loss of average 355 methylation levels in all DMR categories in the E6.5 epiblast and ExE, except for epiblast High-356 Mid DMRs ( Figure 5A , Table S3 ) for which a compensatory mechanism provided high levels of 357 methylation (wt: 76.9% vs Dnmt3b -/-: 71.6%). The compensatory mechanism on High-Mid 358
DMRs in response to Dnmt3b-deficiency was ineffective in the E6.5 ExE. When we focused on 359 promoter-TSS for each DMR categories, we observed again that loss of methylation for these 360 regulatory regions was principally associated with Dnmt3b-deficiency ( Figure 5B ). The 361 promoter-TSS regions associated with High-Mid DMRs retained relatively high methylation 362 levels for either Dnmt3a -/or Dnmt3b -/epiblast samples, demonstrating a robust and 363 compensatory de novo methylation mechanism. To further underline the impact of DNMT3A or 364 DNMT3B on the de novo methylation of DMRs, we measured methylation levels for DMRs 365 selected from our gene enrichment analyses (Fgb, P2rx7, Pcyt2, Etnppl, Ralgds, Lrp5) and other 366 genomic segments covered by multiple tiles (Cxxc1, Fcgrt, Lamp5, Mbd1, Lphn1, Pick1, Irf1 ) 367 ( Figure S7 & S8) in Dnmt3a-or Dnmt3b-deficient epiblast and ExE. In line with our global 368 observations, for most DMR-associated tiles, a Dnmt3b-deficiency in E6.5 epiblast or ExE 369 caused a more severe loss of methylation compared to lack of Dnmt3a. However, for some 370 regions in the E6.5 epiblast (e.g., Pick1, Irf1), Dnmt3a -/methylation levels were inferior to those 371 of Dnmt3b -/-. Noteworthy, for most DMRs, lack of co-factor Dnmt3l affected DNA methylation 372 levels to greater extent than Dnmt3a-deficiency ( Figure S6 ). Overall, we show that of DNMT3A 373 and DNMT3B participate in the establishment of the asymmetric methylation patterns associated 374 with the various DMR categories in both embryonic and extraembryonic cells, with DNMT3B 375 being the principal contributor in both cell lineages during the de novo reprogramming wave as it 376 can compensate almost entirely for the absence of DNMT3A. 377 378
Decline in Compensatory DNA Methylation Mechanisms in Response to Dnmt3a-or Dnmt3b-379
Deficiency. 380
As embryonic development progresses from E6.5 to E8.5, our data suggest that lack of 381 DNMT3A or DNMT3B further reduces global methylation levels of DMRs (High-Mid, High-382 Low, Mid-Low and Mid-Mid), evoking that absence of either enzymatic activity causes an 383 additive and extended effect ( Figure 5A-B) . To further define the robustness in compensatory 384 mechanism between DNMT3A or DNMT3B in the establishment and maintenance of DNA 385 methylation on DMRs categories, we focused on High-Mid promoter-TSS-associated DMRs as 386 they have the highest DNA methylation levels and require the most de novo methyltransferase 387 activity. Methylation differences of ≥ 20% between wild-type and Dnmt3a-or Dnmt3b-deficient 388 samples were considered as regions showing substantial lack of compensation. In agreement 389 with our results ( Figure 5A-B) , we observed that at E6.5, DNMT3B can compensate almost 390 entirely for DNMT3 Aloss by maintaining methylation levels on most promoters-TSS associated 391 tiles in the epiblast (410/437 = 93.8%) and ExE (558/602 = 92.7%), whereas DNMT3A can only 392 partially alleviate the lack of DNMT3B in the epiblast (315/410 = 78.6%) and ExE (244/524 = 393 46.6%) ( Figure 6A-B ). As embryonic cell lineages development evolves between E6.5 and E8.5, 394 global methylation levels increase on promoter-TSS of High-Mid DMRs. However, we detected 395 a sharp decline in the compensatory mechanism to rescue the de novo and/or maintenance of 396 methylation levels of promoter-TSS DMRs in the Dnmt3a-(524/627 = 80.9%) or Dnmt3b-397 (256/622 = 41.2%) deficient E8.5 embryos. This is further highlighted when we focus on a 398 subgroup of 314 promoter-TSS associated tiles overlapping all of 9 data sets ( Figure 6C With recent breakthroughs in high-throughput sequencing, we now have a better 411 understanding of the dynamic of DNA methylation erasure occurring in early cleavage stage 412 embryos following fertilization. However, the discrepancies in acquisition of genome-wide DNA 413 methylation patterns in early post-implantation embryonic and extraembryonic cell lineages 414 remain to be methodically delineated. To address this issue and further our understanding of the 415 DNA methylation asymmetry that guides the developmental trajectory of embryonic and 416 extraembryonic cell lineages, we established genome-wide DNA methylation profiles of mouse 417 embryo and placenta at mid-gestation, and analyzed various publicly available developmental 418 stage specific embryo and placenta DNA methylation datasets. Using this strategy, we uncovered 419 that 45% of the genomic regions analyzed differ in DNA methylation status (≥20%) between 420 mid-gestation embryo and placenta, and that these DMRs can be further divided into categories 421 based on their levels of DNA methylation (Low; <20%, Mid; ≥ 20 to <80%, High; ≥ 80%) in the 422 embryo and placenta. We show that the embryo and placenta acquire specific DMR categories 423 during the early stage of the de novo DNA methylation wave, and that these DMRs persist 424 throughout prenatal development, as well as into somatic adult tissues. Furthermore, we show 425 that Dnmt3b primarily drives the divergence in DNA methylation levels associated with these 426 specific DMRs and that de novo methyltransferase activity of Dnmt3b can almost entirely 427 compensate for lack of Dnmt3a in the asymmetric establishment of embryonic and placental 428
DMRs, but that Dnmt3a can only partially palliate the absence of Dnmt3b. However, with 429 developmental progression, this compensatory DNA methylation mechanism becomes less 430 effective. 431
Our results indicate that the kinetics of DNA methylation acquisition leading to specific 432 embryo-placenta DMR categories is not a stepwise process occurring throughout cell fate 433 decisions and patterning of embryonic and extraembryonic lineages, but a prompt progression in 434 the early post-implanted conceptus. These results are in line with studies reflecting that the 435 initiation of asymmetric DNA methylation levels begins within the trophoblast and the inner cell between E4.5 and E6.5 is particularly key to establishing asymmetric DNA methylation patterns 440 associated with mid-gestation embryo-placenta DMR classes, and that these DMR associated-441 patterns are long-lasting across stages of prenatal development. Since we studied cell populations 442 derived from embryonic and placental tissues, we cannot dismiss the prevalence of cell-to-cell 443 heterogeneity in the acquisition kinetics of specific DMR patterns. Despite this concern, our 444 results indicate that embryonic cells have a large body of DMRs with High-levels (≥80%) and 445
Low-levels (<20%) of methylation that remain static across development, as well as in somatic 446 cell types (High-Mid & High-Low DMRs), whereas compared to the embryo, the placental 447
DMRs have overall lower methylation levels and are more broadly distributed amongst 448 methylation levels, which has also been shown in other studies where genome-wide DNA 449 methylation profiles of placental cells were compared to other tissues and specific cell types 450 (Schroeder et al., 2013; Chatterjee et al., 2016; Smith et al., 2017) . Lower methylation levels in 451 the placenta have been associated with reduced de novo methyltransferase activity in the ExE 452 during the de novo reprogramming wave (Fulka et al., 2004 , Santos et al., 2002 . Nevertheless, 453
we observe methylation level peaks for all DMR categories within the ExE at E6.5 before levels 454 stabilize at E10.5. As of now, the implication of these methylation level peaks on future 455 regulation mechanisms and methylation profiles is unknown. Moreover, it remains to be 456 determined whether global reduction in DNA methylation marks on DMRs between the E6.5 and 457 E10.5 extraembryonic cell lineages is stochastic or targeted, and whether it occurs through 458 passive or active mechanisms. 459
We also observed an enrichment of retrotransposons (i.e., LINE, SINE, LTR) in DMRs 460 especially in those with High-levels of methylation in the embryo and lower-levels in the 461 placenta, whereas DMRs with Low-levels of methylation in the embryo and higher levels in the 462 placenta are preferentially outside retrotransposons-associated sequences. Earlier findings of 463 Chapman et al. (Chapman et al., 1984) revealed that repeat regions in the placenta appear to lack 464 tight control of their methylation patterns, perhaps indicating that maintaining methylation, and 465 therefore repression of these elements for genome stability and integrity, is not critical given the 466 relatively short lifespan of this organ. However, we do observe Mid-range methylation levels 467 (20-80%) in the placenta for a substantial portion of DMRs that are associated with 468 retrotransposons, revealing that specific genomic regions associated with repetitive elements do 469 that in the absence of DNMT3B, DNMT3A was not able to counterbalance, leading to the loss of 480 promoter-CGI methylation and gain of expression of germline genes (e.g., Sycp1, Sycp2, Mael, 481
Rpl10l, Dmrtb1) in somatic cells of the embryo. Here, we show that the promoter of these 482 germline genes, associated with meiotic and piRNA processes as well as other genes with similar 483 biological functions, are highly enriched in High-Mid DMRs. We also reveal that for this 484 particular set of High-Mid DMRs, mainly deprived of CGIs, DNMT3A is able to substantially 485 counterbalance the lack of DNMT3B in the E6.5 epiblast and establish global DNA methylation 486 levels, whereas in the ExE, this compensatory mechanism is rather inefficient. Globally, we 487
show that DNMT3B is much more potent at compensating than DNMT3A in both the epiblast 488 and ExE for all DMR categories, indicating that DNMT3B is the main de novo enzyme driving 489 asymmetric DNA methylation patterns between the embryo and placenta. Although 490 compensatory mechanisms have been observed in Dnmt3a or Dnmt3b-depleted conceptuses, we 491 still do not fully understand the process as Dnmt3a and Dnmt3b have cell lineage specific 492 expression during the peri-implantation developmental period. As development progresses, we 493 observed that the compensation mechanism in Dnmt3a or Dnmt3b-deficient embryos remains 494 apparent at E8.5 on most DMR categories, but is less effective as the methylation gaps increase 495 compared to wild-type. This correlates with a developmental period where DNMT3A is now the 496 main de novo methyltransferase enzyme in both the embryo and placenta (Okano et al., 1999 , 497 Watanabe et al., 2002 , and with a compensatory activity of DNMT3A being less effective. This 498 suggests that DNMT3B activity is critical to ensure proper establishment of DNA methylation 499 asymmetry between the embryonic and extraembryonic cell lineages during the de novo 500 reprogramming wave, but that DNMT3A is required during the developmental progression to 501 safeguard methylation levels on DMR categories. 502
CONCLUSION 504
We demonstrate that asymmetry between embryo and placenta DNA methylation patterns 505 occurs rapidly during de novo acquisition of methylation marks in the early post-implanted 506 conceptus, and that these patterns are long-lasting across subtypes of DMRs. We also reveal that 507 at the peri-implantation stages, de novo methyltransferase activity of DNMT3B is the main 508 provider of asymmetric methylation marks on DMRs, and that it largely palliates the lack of 509 DNMT3A in the epiblast and ExE. However, as development progresses, DNMT3A becomes the 510 principal de novo methyltransferase by mid-gestation, and DNMT3B methyltransferase activity 511 is less effective at promoting compensation. These results further underline why embryos 512 developing without DNMT3B have severe DNA methylation defects and die at mid-gestation, 513
whereas those without DNMT3A only die postnatally. Further investigation is required to 514 determine the molecular mechanisms controlling the precise de novo acquisition of long-lasting 515 methylation marks on specific DMR subtypes in the embryonic and extraembryonic cell 516 associated with the different DMR categories at E10.5, and their methylation levels in the 808 different tissues and genotypes at E6.5 and E8.5. B) Promoter-TSS density graphs for E10.5 809 embryo and E6.5 epiblast (wt, Dnmt3a -/and Dnmt3b -/-) (left panel) and for E10.5 placenta and 810 E6.5 extraembryonic ectoderm (wt, Dnmt3a -/and Dnmt3b -/-) (right panel). E: embryo, Epi: 811 epiblast, ExE: extraembryonic ectoderm. See Table S3 for median and mean methylation values, 812
and Table S4 for number of overlapping tiles analysed. 813 814 815
